Breast Cancer Tumor Care Observational Programme

Completed

• Conditions: Post Menopausal; Arthralgia
• Interventions: Drug: anastrozole

• Registration Number: NCT00660244
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of this study is to investigate efficacy and tolerability under anastrozole (Arimidex) treatment.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-02
• Study First Submitted: 2008-04-15
• Study First Submitted QC: 2008-04-15
• Study First Posted: 2008-04-17
• Study Completion: 2009-12
• Status Verified: 2012-06
• Last Update Submitted: 2012-06-05
• Last Update Posted: 2012-06-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 150

Inclusion Criteria

• Postmenopausal women
• Already on upfront Arimidex Therapy (Start 1-4 weeks before)
• HR+

Exclusion Criteria

• Premenopausal women
• Tamoxifen switch patients

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
1	anastrozole	-

Primary Outcome Measures

Name	Time	Method
Progression of disease and tolerability in general	Baseline, every 3 month

Secondary Outcome Measures

Name	Time	Method
Patient questionnaire to collect data on Incidence, time of onset and treatment of arthralgia	Baseline, every 3 month

Trial Locations

Locations (1)

Research Site; 🇦🇹 Graz, Austria